GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds  statnews.com Weight loss drugs linked to higher risk of eye damage in

Anecdotes abound about “Ozempic babies”—when women wound up with unplanned pregnancies while taking both birth-control and the popular GLP-1 drugs for diabetes or weight loss. 

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness,

Women using GLP-1 weight-loss drugs must use effective contraception, the MHRA has warned, citing unknown risks to pregnancy and foetal health. Medscape News UK

Women in bathing suits lined up on the beach in 1949. | FPG/Getty Images For decades, women have heard about the mythical “summer body” —

GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications seeing weight reductions of 5%–18% in clinical trials, along

Women who take weight loss drugs should use barrier contraception if they are seeking to avoid pregnancy, the medicines regulator has advised.The Medicines and Healthcare

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite rising temperatures and hazy skies looming over the Pharmalot

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s hard

Good morning. The best part about having a library card is that even when you have three overdue books, you can still request new ones

In a move to put its money where its mouth is, digital health startup Virta Health said it’s now guaranteeing employers they won’t see increased

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should continue GLP-1 RAs and adhere to a 1-day clear liquid

When it rebranded as WW, it looked like the writing was on the wall for WeightWatchers. BBD Perfect Storm Health’s Nick Dutnall believes the brand

In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice

Over two thirds of patients with hidradenitis suppurativa experience fewer flares, new lesions, and improved quality of life while using GLP-1 receptor agonists. Medscape Medical

The popularity of glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Wegovy, has significantly surged in recent years, with 1 in 8 Americans now

Once-daily fixed-ratio combination therapies of basal insulin and a GLP-1 receptor agonist such as insulin degludec with liraglutide (IDegLira) and insulin glargine U100 with lixisenatide

GLP-1 users taking drugs like Ozempic and Wegovy are spending less on eating at restaurants and on take-out dinners, according to a new report from

To the Editor A recent network meta-analysis reported that sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk

Post Content

Bad breath is a commonly reported side-effect of weight loss drugs. antoniodiaz/ Shutterstock Ozempic and Wegovy have been hailed as wonder drugs when it comes

BMI is calculated using your height and weight. It’s been criticized as a measurement of an individual’s health, but is being used to identify who

New research has indicated a 33% higher incidence of kidney cancer among Ozempic users compared to non-users Ozempic and similar weight loss medications may increase

Post Content

Eli Lilly has tapped Camurus in a deal worth up to $870 million for its drug delivery technology to develop four long-acting incretin candidates. The

Nature Metabolism, Published online: 04 June 2025; doi:10.1038/s42255-025-01305-x In this paper, the authors describe the energy state-dependent regulation of the PVNGLP-1R to DVC circuit, resulting

Four clinical organizations jointly release an advisory with evidence-based nutrition and lifestyle interventions to enhance GLP-1 treatment outcomes for obesity. Medscape Medical News

Eli Lilly (NYSE: LLY) has been a growth beast over the years and is now easily the most valuable healthcare company in the world, with

New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To

Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1 (GLP-1)/gastric inhibitory polypeptide (GIP)

Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to conceive.

(MedPage Today) — The Obesity Society, along with several other organizations, jointly released a clinical advisory on nutritional priorities for supporting patients on GLP-1 receptor

For patients with type 2 diabetes (T2D) who haven’t adequately controlled their blood glucose, taking the glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide may benefit from